Open Access Published by De Gruyter November 26, 2020

Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?

Michael Stiehm, Christoph Brandt-Wunderlich, Stefan Siewert, Klaus-Peter Schmitz, Niels Grabow, Leonid Goubergrits, Titus Kühne, Eric K. W. Poon, Andrew Ooi and Peter Barlis